Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMKR vs GSK✓SelectedUSD · GSKAMKR vs GSK performance historyLatest closeAs of-2.72%11/13
Stock and ETF performance explorer

AMKR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+192.5%
GSK return
+207.1%
Excess return
-14.6%
Maximum drawdown
-98.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.7%+0.5%-3.2%-3.0%
7D+10.0%+1.1%+8.9%+9.4%
30D-19.4%+6.3%-25.8%-22.3%
3M-37.4%+1.8%-39.2%-38.9%
6M-51.5%+1.7%-53.1%-53.6%
YTD-8.1%+6.5%-14.6%-15.0%
1Y+13.8%+9.5%+4.3%+3.9%
3Y+59.4%+65.3%-5.9%+11.4%
5Y+65.9%+43.7%+22.1%+20.9%
10Y+238.6%+104.1%+134.5%+100.1%
All+192.5%+207.1%-14.6%+30.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling